Canadian advocacy association that promotes the health needs of children and youth is seeking more research on the safety, dosing and efficiency of medical cannabis in clinical practice.
The Canadian Paediatric Society (CPS) noted a lack of studies on medical marijuana for children under 18 in an Oct. 19 position statement on its website.
“Despite many therapeutic claims, there are few rigorous studies to inform the dosing, safety, and efficacy of medical cannabis used in pediatric clinical practice,” CPS said last week.
See also: Cannabis Gave Her Child A Future: Now She Helps Other Families
“Given the widespread use of medical cannabis in Canada, pediatricians should be prepared to engage in open, ongoing discussions with families about its potential benefits and risks, and develop individualized plans that monitor efficacy, reduce harms, and mitigate drug−drug interactions,” the authors wrote in the abstract.
The recommendations from Lauren E. Kelly, PhD, Michael J. Rieder, MD and Yaron Finkelstein, MD are focused on safety, considerations for families and caregivers, such as side effects and cost as well as considerations for clinicians when authorizing medical cannabis for children.
According to the statement, the counseling should:
- be evidence-based and unbiased;
- help parents make informed, shared decisions about their child’s care;
- alert parents to the risks and implications of accessing cannabis through recreational sources.
Recent Study On Alcohol And Cannabis Use Among Youth
Meanwhile, public health officials are worried by recent survey results which suggest prevalent alcohol and cannabis use among students in Prince Edward Island.
The survey’s participants included students in Grades 7 to 12 during the last school year, reported CBC News.
The findings suggest that 27 percent of students in junior high and high school consumed alcohol in the previous month, out of which 16% said they binge drink. Roughly 13% of those surveyed reported using cannabis, surpassing the national average by 4%.
Now read: Children's Palliative Care & Medical Cannabis: Australian Researchers Conduct Pilot Study
Photo: Courtesy of Kimzy Nanney on Unsplash
Did you miss the first wave of cannabis investments? Don’t make that mistake again.
Experts believe cannabis stocks have found their floor and are now poised for unprecedented growth.
Join Benzinga PotProfits. Benefit from Michael Berger's sharp analysis, revealing top cannabis stock opportunities and timely updates.
Experience the potential of 10%+ returns in just 90 days. Our 4.5-star Marketfy rating speaks volumes. Secure your position in this booming sector with a 30-day money-back guarantee. The time to invest is now, before everyone else realizes it. Secure your profits with Benzinga. Click here now to learn more.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving – don’t get left behind!
Curious about what’s next for the industry and how to leverage California’s unique market?
Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!
Get your tickets now to secure your spot and avoid last-minute price hikes.